[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2470M - Therapeutic composition. - Google Patents

Therapeutic composition.

Info

Publication number
FR2470M
FR2470M FR890933A FR890933A FR2470M FR 2470 M FR2470 M FR 2470M FR 890933 A FR890933 A FR 890933A FR 890933 A FR890933 A FR 890933A FR 2470 M FR2470 M FR 2470M
Authority
FR
France
Prior art keywords
therapeutic composition
therapeutic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR890933A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Priority to FR890933A priority Critical patent/FR2470M/en
Application granted granted Critical
Publication of FR2470M publication Critical patent/FR2470M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
FR890933A 1962-03-13 1962-03-13 Therapeutic composition. Active FR2470M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR890933A FR2470M (en) 1962-03-13 1962-03-13 Therapeutic composition.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR890933A FR2470M (en) 1962-03-13 1962-03-13 Therapeutic composition.

Publications (1)

Publication Number Publication Date
FR2470M true FR2470M (en) 1964-04-20

Family

ID=87519709

Family Applications (1)

Application Number Title Priority Date Filing Date
FR890933A Active FR2470M (en) 1962-03-13 1962-03-13 Therapeutic composition.

Country Status (1)

Country Link
FR (1) FR2470M (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440355A1 (en) * 1978-10-31 1980-05-30 Proter Spa THIOLIC DERIVATIVES OF PROPIONAMIDOACETIC ACID FOR THE TREATMENT OF CELLULITE
FR2503151A1 (en) * 1981-04-02 1982-10-08 Morelle Jean Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use
FR2509175A1 (en) * 1981-03-06 1983-01-14 Toyo Jozo Kk THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES
WO1987004923A2 (en) * 1986-02-14 1987-08-27 Dominique Robert Aromatic amides absorbing the u.v.
FR2601876A1 (en) * 1986-07-24 1988-01-29 Inpharzam Int Sa WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL CYSTEINE AND CITRIC ACID
EP0317540A1 (en) * 1987-11-19 1989-05-24 Aktiebolaget Draco Cysteine derivatives, processes for their preparation and their use
DE3739401A1 (en) * 1987-11-20 1989-06-01 U Prof Dr Med Leuschner Pharmaceutical preparation for cholelitholysis (dissolution of gallstones)
EP0343268A1 (en) * 1988-05-25 1989-11-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440355A1 (en) * 1978-10-31 1980-05-30 Proter Spa THIOLIC DERIVATIVES OF PROPIONAMIDOACETIC ACID FOR THE TREATMENT OF CELLULITE
FR2509175A1 (en) * 1981-03-06 1983-01-14 Toyo Jozo Kk THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES
FR2503151A1 (en) * 1981-04-02 1982-10-08 Morelle Jean Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use
EP0235064A3 (en) * 1986-02-14 1988-04-13 Dominique Robert Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing uvb and/or uva
WO1987004923A2 (en) * 1986-02-14 1987-08-27 Dominique Robert Aromatic amides absorbing the u.v.
EP0235064A2 (en) * 1986-02-14 1987-09-02 Dominique Robert Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing UVB and/or UVA
WO1987004923A3 (en) * 1986-02-14 1987-09-24 Dominique Robert Aromatic amides absorbing the u.v.
FR2601876A1 (en) * 1986-07-24 1988-01-29 Inpharzam Int Sa WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL CYSTEINE AND CITRIC ACID
BE1000355A3 (en) * 1986-07-24 1988-11-08 Inpharzam Internat Sa WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND CITRIC ACID.
EP0317540A1 (en) * 1987-11-19 1989-05-24 Aktiebolaget Draco Cysteine derivatives, processes for their preparation and their use
WO1989004825A1 (en) * 1987-11-19 1989-06-01 Aktiebolaget Draco New derivatives of cysteine, processes for their preparation and their use
DE3739401A1 (en) * 1987-11-20 1989-06-01 U Prof Dr Med Leuschner Pharmaceutical preparation for cholelitholysis (dissolution of gallstones)
EP0343268A1 (en) * 1988-05-25 1989-11-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same

Similar Documents

Publication Publication Date Title
FR2973M (en) Alpha-aminoketone.
FR1361973A (en) Combined helicopter-airplane
DK112125B (en) Falstagsten.
DK105974C (en) Lastpallemagasin.
FR2470M (en) Therapeutic composition.
FR3021M (en) Analgesic compositions.
NL143659B (en) FLUIDUM-AND-CLOSURE.
BR6346411D0 (en) ANTIELMINTIC COMPOSITION
FR2592M (en) Substituted phenylbicyclononanes.
FR3418M (en) Analgesic composition.
FR3546M (en) Azabenzocycloalkane-n-carboxamidines.
OA01221A (en) Polythioformaldehydes.
FR3088M (en) Substituted 2-oxo-tetrahydroquinolines.
FR1373M (en) Therapeutic composition.
DK104485C (en) Combine.
DK105241C (en) Combine.
DK107262C (en) Combine.
FR2894M (en) Phenylalkanolamine.
DK103099C (en) Plov.
FR1173M (en) Therapeutic compositions.
DK106702C (en) Combine.
DK99904C (en) Combine.
FR3145M (en) Anorexogenic compositions.
DK102772C (en) Sparebosse.
FR3358M (en) 3-methylene-steroids.